Actively Recruiting

Age: 18Years +
All Genders
ID06320236

Emergency Medicine Pulmonary Embolism Testing Multicentre Study

Led by Dr. Kerstin de Wit · Updated on 2026-04-20

4000

Participants Needed

4

Research Sites

52 weeks

Total Duration

On this page

Sponsors

D

Dr. Kerstin de Wit

Lead Sponsor

C

Canadian Institutes of Health Research (CIHR)

Collaborating Sponsor

AI-Summary

What this Trial Is About

Researchers are evaluating a new clinical decision tool called Adjust-Unlikely to improve the testing process for pulmonary embolism in emergency department patients suspected of having this condition. Pulmonary embolism diagnosis is critical to prevent death and long-term disability, but current imaging tests expose patients to radiation, are costly, time-consuming, and sometimes lead to false positives. This observational study aims to validate the Adjust-Unlikely rule, which has been developed with input from physicians and patients to reduce unnecessary imaging safely and effectively. The Adjust-Unlikely tool combines physician judgment with D-dimer blood test results and imaging scans when needed. It categorizes patients based on whether pulmonary embolism is considered the most likely diagnosis and uses age-adjusted D-dimer thresholds to decide if imaging is necessary. Local laboratory D-dimer assays will be used for testing. The study includes emergency department patients tested for pulmonary embolism and will observe their outcomes without assigning treatments. Participants will be monitored for 30 and 90 days to track venous thrombosis events and the accuracy of the Adjust-Unlikely testing at the time of their emergency visit. Data collection involves recording physician assessments, D-dimer test results, and any imaging done. The study will help determine if this decision rule can safely reduce unnecessary imaging and improve care during emergency visits. The study is expected to continue until September 2027.

CONDITIONS

Brief Title

Emergency Medicine Pulmonary Embolism Testing Multicentre Study

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Emergency department patient who is tested by an emergency physician for PE
  • Age 18 years or older
Not Eligible

You will not qualify if you...

  • Patient is younger than 18 years
  • No documentation of whether PE is the most likely diagnosis
  • D-dimer is not tested or not resulted during the emergency visit
  • D-dimer level is known before documentation of whether PE is the most likely diagnosis
  • D-dimer ordered before physician assessment
  • Patient opted out of all research at the site
  • Patient leaves against medical advice
  • PE or deep vein thrombosis imaging within prior 30 days
  • New non-PE indication for anticoagulation
  • Treatment for presumed PE started before testing
  • Previously enrolled in the study
  • Prior lower extremity deep vein thrombosis without baseline ultrasound
  • Patient transferred from another hospital
  • Patient does not reside in Ontario
  • No valid Ontario Health Insurance Plan card

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

1 visit (in-person)

Diagnostic Evaluation

Duration - Single emergency department visit

Participants undergo diagnostic testing to assess for pulmonary embolism during emergency department assessment.

1 visit (in-person)

Long-term Monitoring

Duration - Up to 90 days

Participants are monitored for venous thrombosis events following the diagnostic evaluation.

Follow-up assessments may occur depending on clinical care

Trial Site Locations

Total: 4 locations

1

Hamilton Health Sciences Corporation

Hamilton, Ontario, Canada, L8L 2X2

Actively Recruiting

2

Kingston Health Sciences Centre

Kingston, Ontario, Canada, K7L 2V7

Actively Recruiting

3

London Health Sciences Centre Research Inc

London, Ontario, Canada

Active, Not Recruiting

4

Ottawa Hospital Research Institute

Ottawa, Ontario, Canada, K1Y 4E9

Active, Not Recruiting

Loading map...

Research Team

N

Natasha S Clayton

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

1

Similar Trials

A Multicenter Prospective Cohort Study Comparing Random Biop...

Barrett Esophagus

Actively Recruiting

1 location

Mobility Outcomes in Post-Pulmonary Embolic Disease (MOPED):...

Pulmonary Embolism

Actively Recruiting

1 location

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here